# Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients

> **NCT02944045** · PHASE3 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 222 (estimated)

## Conditions studied

- Pneumocystis
- Steroids
- Immunocompromised Patient
- Hematologic Neoplasms
- Immunosuppressive Agents
- Neoplasms

## Interventions

- **DRUG:** Methylprednisolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02944045
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-15
- **Primary completion:** 2021-10
- **Final completion:** 2022-10
- **Target enrollment:** 222 (ESTIMATED)
- **Last updated:** 2020-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02944045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02944045, "Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02944045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*